Sun Pharma Falls Most in Two Months After Profit Misses Views
Sun Pharmaceutical Industries Ltd., India's largest drugmaker, fell the most in two months after reporting fourth-quarter earnings that missed analyst estimates amid higher investments and regulatory pressures. The stock fell as much as 4.6 percent to 775 rupees, the biggest drop since March 29 on an intra-day basis.